Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Mouse|
|Published species reactivity||Mouse|
|Host / Isotype||Rat / IgG2b, kappa|
|Immunogen||The CD45 antigen|
|Contains||0.1% sodium azide|
|Storage Conditions||4° C, store in dark|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay Dependent|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Flow Cytometry (Flow)||See 4 publications below|
CD45 (LCA, leukocyte common antigen) is a receptor-type protein tyrosine phosphatase ubiquitously expressed in all nucleated hematopoietic cells, comprising approximately 10% of all surface proteins in lymphocytes. CD45 glycoprotein is crucial in lymphocyte development and antigen signaling, serving as an important regulator of Src-family kinases. CD45 protein exists as multiple isoforms as a result of alternative splicing; these isoforms differ in their extracellular domains, whereas they share identical transmembrane and cytoplasmic domains. These isoforms differ in their ability to translocate into the glycosphingolipid-enriched membrane domains and their expression depends on cell type and physiological state of the cell. Besides the role in immunoreceptor signaling, CD45 is important in promoting cell survival by modulating integrin-mediated signal transduction pathway and is also involved in DNA fragmentation during apoptosis. CD45RA is an isoform of the CD45 complex and has restricted expression between different subtypes of lymphoid cells.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.
MCD4530 was used in flow cytometry to identify a relationship between resistant cancers and myeloid-derived suppressor cells
|Kim K,Skora AD,Li Z,Liu Q,Tam AJ,Blosser RL,Diaz LA,Papadopoulos N,Kinzler KW,Vogelstein B,Zhou S||Proceedings of the National Academy of Sciences of the United States of America (111:11774)||2014|
CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice.
MCD4530 was used in flow cytometry to determine the role of CD4+ T cells during mutant Kras-driven pancreatic carcinogenesis
|Zhang Y,Yan W,Mathew E,Bednar F,Wan S,Collins MA,Evans RA,Welling TH,Vonderheide RH,di Magliano MP||Cancer immunology research (2:423)||2014|
Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.
MCD4530 was used in flow cytometry to demonstrate that IL-6 is required for the maintenance and progression of pancreatic cancer precursor lesions.
|Zhang Y,Yan W,Collins MA,Bednar F,Rakshit S,Zetter BR,Stanger BZ,Chung I,Rhim AD,di Magliano MP||Cancer research (73:6359)||2013|
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background.
MCD4530 was used in flow cytometry to investigate nanoparticle clearance.
|Jones SW,Roberts RA,Robbins GR,Perry JL,Kai MP,Chen K,Bo T,Napier ME,Ting JP,Desimone JM,Bear JE||The Journal of clinical investigation (123:3061)||2013|
B220; c polypeptide; CD45; CD45 antigen; CD45R; GP180; L-CA; LCA; leukocyte common antigen; LY5; lymphocyte antigen 5; lymphocyte common antigen; protein tyrosine phosphatase; receptor type; receptor-type tyrosine-protein phosphatase C; T200 glycoprotein; T200 leukocyte common antigen
B220; Cd45; CD45R; L-CA; loc; Ly-5; Lyt-4; T200